FIELD: medicine, endocrinology, pharmacy.
SUBSTANCE: invention relates to medicinal agents, in particular, to the hormonal pharmaceutical composition. Invention proposes new pharmaceutical compositions and a method for preparing such compositions formed by the estrogen-gestagen combination with a single gestagen compound in mixture with one or some nontoxic, inert pharmaceutically acceptable carriers designated for oral administration. Also, invention relates to the estrogen-gestagen mixture wherein estrogenic component and gestagenic component are used by the combined method. Proposed composition is designated for treatment of estrogenic insufficiency, prophylaxis of osteoporosis and cardiovascular diseases in women in the menopause period. Invention provides the development of the new estrogen-gestagen combination showing activity in the oral route of applying and administrated by the combined method.
EFFECT: improved and valuable medicinal properties of composition.
12 cl, 8 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONTRACEPTIVE MEDICINAL AGENT BASED ON GESTAGEN AND ESTROGEN AND METHOD FOR ITS PREPARING | 2000 |
|
RU2258512C2 |
| METHOD FOR APPLYING HORMONE COMPOSITION CONTAINING A COMBINATION OF ESTROGEN AND PROGESTAGEN | 1997 |
|
RU2274450C2 |
| MIXED PREPARATION BASED ON NATURAL ESTROGENS FOR CONTRACEPTION | 1996 |
|
RU2113849C1 |
| INTERRUPTED HORMONE-SUBSTITUTION THERAPY WITH LOW ESTROGEN DOSAGES | 2000 |
|
RU2245713C2 |
| HORMONAL SUBSTITUTIONAL THERAPY | 1994 |
|
RU2139056C1 |
| DROSPIRENONE FOR HORMONAL REPLACEMENT THERAPY | 2005 |
|
RU2402331C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF ESTRA-1,3,5(10)-TRIENE | 1995 |
|
RU2179442C2 |
| METHOD FOR ENHANCING OF TESTOSTERONE AND ANALOGOUS STEROID LEVELS IN FEMALES | 2001 |
|
RU2286787C2 |
| DROSPYRENON FOR REPLACEMENT HORMONOTHERAPY | 2001 |
|
RU2275198C2 |
| METHOD FOR PREVENTION OF HORMONE RESISTANCE IN ENDOMETRIAL HYPERPLASIA | 2010 |
|
RU2445962C1 |
